Wyoming Medical Center INC

Wyoming Medical Center INC was paid $4.40M by Medicaid between Jan 2018 and Nov 2024, across 64 billing codes. Its largest line is 99284, emergency room visit (serious) — 42% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,024	$582K
2019	7,441	$544K
2020	5,031	$368K
2021	14,342	$611K
2022	23,781	$832K
2023	25,222	$824K
2024incomplete	20,074	$638K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	42%	12,296	11,435	$1.84M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	22%	9,365	8,938	$987K
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	11%	6,348	3,668	$474K
A0427	Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)	8.5%	4,713	2,910	$374K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	5.1%	3,165	2,894	$225K
A0425	Ground mileage, per statute mile	3.3%	13,530	7,836	$146K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.6%	824	707	$115K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	1.7%	1,819	1,192	$73K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,480	1,215	$41K
87631		<1%	949	807	$34K
71045	Radiologic examination, chest; single view	<1%	1,018	889	$23K
96375	Therapeutic injection; each additional sequential IV push	<1%	600	515	$14K

52 more codes

U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	142	$9K
80053	Comprehensive metabolic panel	<1%	12,345	$6K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	578	$6K
87081		<1%	953	$5K
71046	Radiologic examination, chest; 2 views	<1%	110	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	16,665	$3K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	61	$3K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	32	$2K
86900		<1%	39	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	39	$2K
36415	Collection of venous blood by venipuncture	<1%	1,530	$1K
87150		<1%	30	$1K
87088		<1%	295	$1K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,919	$975.03
85027		<1%	1,119	$925.02
70450	Computed tomography, head or brain; without contrast material	<1%	12	$912.76
84443	Thyroid stimulating hormone (TSH)	<1%	76	$825.67
86780		<1%	53	$811.50
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	51	$800.00
96361	Intravenous infusion, hydration; each additional hour	<1%	14	$734.17
86762		<1%	38	$651.60
86703		<1%	51	$619.36
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	1,446	$579.97
80048	Basic metabolic panel (calcium, ionized)	<1%	1,255	$573.80
87400		<1%	19	$573.04
87340		<1%	38	$493.62
87634		<1%	100	$230.07
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	143	$226.20
83605		<1%	1,280	$123.34
J3490	Unclassified drugs	<1%	1,128	$98.71
82803		<1%	1,065	$76.89
81001		<1%	613	$43.74
83735		<1%	742	$34.38
80069		<1%	16	$31.95
87086	Culture, bacterial; quantitative colony count, urine	<1%	36	$27.84
83690		<1%	459	$21.88
84484		<1%	174	$19.82
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,356	$15.66
84703		<1%	287	$12.64
86140		<1%	93	$5.18
84100		<1%	200	$3.98
85610		<1%	406	$3.42
85652		<1%	46	$2.70
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	445	$1.17
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	77	$0.98
J2704	Injection, propofol, 10 mg	0%	51	$0.00
85730		0%	15	$0.00
86901		0%	39	$0.00
86850		0%	39	$0.00
G0378	Hospital observation service, per hour	0%	18	$0.00
82805		0%	56	$0.00
84145		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPORTER, LANCE (CEO)